BETOPTIC EYE DROPS 0.5% BOTTLE 5ML

Active ingredient

Betoptik eye drops:
1 ml of drops of betaxolol hydrochloride 5.6 mg;
in vials of 5 ml with a dropper cap.

Mechanism of action

Betoptic - antiglaucoma drug. Selective beta1-adrenergic blocker without internal sympathomimetic activity. Does not possess membrane stabilizing (local anesthetic) action.
When applied topically, betaxolol reduces intraocular pressure by reducing the production of intraocular fluid.
The onset of hypotensive action is observed 30 minutes after instillation, the maximum effect develops after 2 hours. After a single instillation, the effect on the IOP remains for 12 hours.
Betaxolol (compared with other beta-blockers) does not cause a decrease in blood flow in the optic nerve.
The use of Betoptic does not lead to the occurrence of miosis, spasm of accommodation, hemeralopia, the effect of "veil" in front of the eyes (unlike miotics).

Indications and usage

Intraocular hypertension; open-angle glaucoma.
It can be used in the treatment of patients with open-angle glaucoma and intraocular hypertension in combination with the pathology of the respiratory tract.

Contraindications

Individual hypersensitivity to Betoptic components.
With care: sinus bradycardia, AV block II – III degree, cardiogenic shock, severe heart failure, myasthenia gravis, diabetes mellitus.

Pregnancy and Breastfeeding

Sufficient experience in the use of Betoptic during pregnancy, breastfeeding is not. It is possible to use Betoptic for treating pregnant and lactating mothers as prescribed by the attending physician if the expected therapeutic effect exceeds the risk of possible side effects.

Dosage and administration

In the conjunctival sac. 1-2 drops 2 times a day.

Adverse reactions

Local: most often - short-term discomfort in the eyes after instillation and tearing. In some cases - point keratitis, decreased corneal sensitivity, photophobia, tearing, itching, dry eyes, redness of the eyes, anisocoria and photophobia.
Systemic reactions (such as insomnia, depressive disorders) are rare.

The use of Betoptic for treating children may be prescribed by a doctor if the expected therapeutic effect exceeds the risk of side effects.

Storage conditions

Store in a dry place protected from light, out of reach of children, at a temperature not exceeding 20 ° C.

Betoptic ophthalmic